Literature DB >> 16161723

Cognitive ability as a factor in engagement in drug abuse treatment.

Elizabeth C Katz1, Stuart D King, Robert P Schwartz, Eric Weintraub, Wardell Barksdale, Robert Robinson, Barry S Brown.   

Abstract

This study examined correlates of high (HCA) and low (LCA) cognitive ability among substance dependent individuals who participated in an ongoing study of early engagement strategies. Participants (55% male; 98% African American), were administered the ASI, Shipley Institute of Living Scale, Beck Hopelessness scale, and TCU Motivation Scales at intake. Analyses were limited to 416 participants whose IQs fell within the upper and lower thirds of the sample. HCA participants reported more prior treatment episodes and longer durations of voluntary abstinence than LCA participants. There were no differences in retention, although HCA participants expressed significantly greater motivation and hopefulness at intake than LCA participants. Results indicate that clients with higher cognitive ability may present with a greater capacity to engage in treatment than individuals with lower cognitive ability.

Entities:  

Mesh:

Year:  2005        PMID: 16161723     DOI: 10.1081/ada-200056767

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  9 in total

1.  Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure.

Authors:  Marc L Copersino; David J Schretlen; Garrett M Fitzmaurice; Scott E Lukas; Judith Faberman; Jody Sokoloff; Roger D Weiss
Journal:  Am J Drug Alcohol Abuse       Date:  2012-03-26       Impact factor: 3.829

2.  Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence.

Authors:  Porche K Henry; Annie Umbricht; Bethea A Kleykamp; Ryan Vandrey; Eric C Strain; George E Bigelow; Miriam Z Mintzer
Journal:  Drug Alcohol Depend       Date:  2012-01-21       Impact factor: 4.492

Review 3.  Cognitive function as an emerging treatment target for marijuana addiction.

Authors:  Mehmet Sofuoglu; Dawn E Sugarman; Kathleen M Carroll
Journal:  Exp Clin Psychopharmacol       Date:  2010-04       Impact factor: 3.157

4.  Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient's Assessment of Own Functioning Inventory (PAOFI).

Authors:  Randall Richardson-Vejlgaard; Sharron Dawes; Robert K Heaton; Morris D Bell
Journal:  Psychiatry Res       Date:  2009-07-19       Impact factor: 3.222

5.  A randomized controlled trial of the effects of working memory training in methadone maintenance patients.

Authors:  Olga Rass; Rebecca L Schacht; Katherine Buckheit; Matthew W Johnson; Eric C Strain; Miriam Z Mintzer
Journal:  Drug Alcohol Depend       Date:  2015-08-24       Impact factor: 4.492

6.  Self-reported attention and mood symptoms in cocaine abusers: relationship to neurocognitive performance.

Authors:  Elysia S Benedict; Ashley Gorman; Wilfred van Gorp; Richard W Foltin; Nehal P Vadhan
Journal:  Psychiatry Res       Date:  2014-06-14       Impact factor: 3.222

7.  Rapid cognitive screening of patients with substance use disorders.

Authors:  Marc L Copersino; William Fals-Stewart; Garrett Fitzmaurice; David J Schretlen; Jody Sokoloff; Roger D Weiss
Journal:  Exp Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.157

8.  Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research.

Authors:  Roman Shrestha; Frederick Altice; Pramila Karki; Michael Copenhaver
Journal:  Front Immunol       Date:  2017-05-11       Impact factor: 7.561

Review 9.  The neuropsychology of amphetamine and opiate dependence: implications for treatment.

Authors:  Karen D Ersche; Barbara J Sahakian
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.